A randomised phase III study comparing high-dose chemotherapy to conventionally dosed chemotherapy for stage III ovarian cancer: the Finnish Ovarian Cancer (FINOVA) study

S Grenman; T Wiklund; J Jalkanen; T Kuoppala; J Mäenpää; A Kuronen; A Leminen; U Puistola; P Vuolo-Merilä; T Salmi; M Vuento; M Yliskoski; M Itälä; H Helenius; H Joensuu; P. Lehtovirta

doi:10.1016/j.ejca.2006.03.021

A randomised phase III study comparing high-dose chemotherapy to conventionally dosed chemotherapy for stage III ovarian cancer: the Finnish Ovarian Cancer (FINOVA) study

S Grenman, T Wiklund, J Jalkanen, T Kuoppala, J Mäenpää, A Kuronen, A Leminen, U Puistola, P Vuolo-Merilä, T Salmi, M Vuento, M Yliskoski, M Itälä, H Helenius, H Joensuu, P. Lehtovirta

Research output: Contribution to journal › Article › Scientific › peer-review

19 Citations (Scopus)

Original language	English
Pages (from-to)	2196-2199
Journal	EUROPEAN JOURNAL OF CANCER
Volume	42
Issue number	14
DOIs	https://doi.org/10.1016/j.ejca.2006.03.021
Publication status	Published - 2006
Publication type	A1 Journal article-refereed

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ejca.2006.03.021

Cite this

Grenman, S., Wiklund, T., Jalkanen, J., Kuoppala, T., Mäenpää, J., Kuronen, A., Leminen, A., Puistola, U., Vuolo-Merilä, P., Salmi, T., Vuento, M., Yliskoski, M., Itälä, M., Helenius, H., Joensuu, H., & Lehtovirta, P. (2006). A randomised phase III study comparing high-dose chemotherapy to conventionally dosed chemotherapy for stage III ovarian cancer: the Finnish Ovarian Cancer (FINOVA) study. EUROPEAN JOURNAL OF CANCER, 42(14), 2196-2199. https://doi.org/10.1016/j.ejca.2006.03.021

@article{d38e08cc545241a1a32b9751aa6b62f7,

title = "A randomised phase III study comparing high-dose chemotherapy to conventionally dosed chemotherapy for stage III ovarian cancer: the Finnish Ovarian Cancer (FINOVA) study",

author = "S Grenman and T Wiklund and J Jalkanen and T Kuoppala and J M{\"a}enp{\"a}{\"a} and A Kuronen and A Leminen and U Puistola and P Vuolo-Meril{\"a} and T Salmi and M Vuento and M Yliskoski and M It{\"a}l{\"a} and H Helenius and H Joensuu and P. Lehtovirta",

year = "2006",

doi = "10.1016/j.ejca.2006.03.021",

language = "English",

volume = "42",

pages = "2196--2199",

journal = "EUROPEAN JOURNAL OF CANCER",

issn = "0959-8049",

publisher = "Elsevier",

number = "14",

}

Grenman, S, Wiklund, T, Jalkanen, J, Kuoppala, T, Mäenpää, J, Kuronen, A, Leminen, A, Puistola, U, Vuolo-Merilä, P, Salmi, T, Vuento, M, Yliskoski, M, Itälä, M, Helenius, H, Joensuu, H & Lehtovirta, P 2006, 'A randomised phase III study comparing high-dose chemotherapy to conventionally dosed chemotherapy for stage III ovarian cancer: the Finnish Ovarian Cancer (FINOVA) study', EUROPEAN JOURNAL OF CANCER, vol. 42, no. 14, pp. 2196-2199. https://doi.org/10.1016/j.ejca.2006.03.021

TY - JOUR

T1 - A randomised phase III study comparing high-dose chemotherapy to conventionally dosed chemotherapy for stage III ovarian cancer: the Finnish Ovarian Cancer (FINOVA) study

AU - Grenman, S

AU - Wiklund, T

AU - Jalkanen, J

AU - Kuoppala, T

AU - Mäenpää, J

AU - Kuronen, A

AU - Leminen, A

AU - Puistola, U

AU - Vuolo-Merilä, P

AU - Salmi, T

AU - Vuento, M

AU - Yliskoski, M

AU - Itälä, M

AU - Helenius, H

AU - Joensuu, H

AU - Lehtovirta, P.

PY - 2006

Y1 - 2006

U2 - 10.1016/j.ejca.2006.03.021

DO - 10.1016/j.ejca.2006.03.021

M3 - Article

SN - 0959-8049

VL - 42

SP - 2196

EP - 2199

JO - EUROPEAN JOURNAL OF CANCER

JF - EUROPEAN JOURNAL OF CANCER

IS - 14

ER -